References
- Org E, Eyheramendy S, Juhanson P, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Hum Mol Genet. 2009;18(12):2288-96.
- Popov VS, Brodsky IB, Balatskaya MN, et al. T-Cadherin Deficiency Is Associated with Increased Blood Pressure after Physical Activity. Int J Mol Sci. 2023;24(18).
- Wain LV. Blood Pressure Genetics and Hypertension: Genome-Wide Analysis and Role of Ancestry. Curr Genet Med Rep. 2014;2:13-22.
- Warren HR, Evangelou E, Cabrera CP, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49(3):403-15.
- Butler MG. Genetics of hypertension. Current status. J Med Liban. 2010;58(3):175-8.
- Seidel E, Scholl UI. Genetic mechanisms of human hypertension and their implications for blood pressure physiology. Physiol Genomics. 2017;49(11):630-52.
- Ehret GB, Caulfield MJ. Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J. 2013;34(13):951-61.
- Lee JH, Shin DJ, Park S, et al. Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population. Yonsei Med J. 2013;54(6):1305-12.
- Yaacov O, Mathiyalagan P, Berk-Rauch HE, et al. Identification of the Molecular Components of Enhancer-Mediated Gene Expression Variation in Multiple Tissues Regulating Blood Pressure. Hypertension. 2024;81(7):1500-10.
- Lee D, Han SK, Yaacov O, et al. Tissue-specific and tissue-agnostic effects of genome sequence variation modulating blood pressure. Cell Rep. 2023;42(11):113351.
- Zhao Y, Blencowe M, Shi X, et al. Integrative Genomics Analysis Unravels Tissue-Specific Pathways, Networks, and Key Regulators of Blood Pressure Regulation. Front Cardiovasc Med. 2019;6:21.
- Lu X, Huang J, Wang L, et al. Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese. Hypertension. 2015;66(4):786-92.
- Moreno C, Williams JM, Lu L, et al. Narrowing a region on rat chromosome 13 that protects against hypertension in Dahl SS-13BN con-genic strains. Am J Physiol Heart Circ Physiol. 2011;300(4):H1530-5.
- Gilibert S, Bataillard A, Nussberger J, et al. Implication of chromosome 13 on hypertension and associated disorders in Lyon hypertensive rats. J Hypertens. 2009;27(6):1186-93.
- Putku M, Kals M, Inno R, et al. CDH13 promoter SNPs with pleio-tropic effect on cardiometabolic parameters represent methylation QTLs. Hum Genet. 2015;134(3):291-303.
- Er LK, Wu S, Cheng T, et al. Genome-Wide Association Study on Adiponectin-Mediated Suppression of HDL-C Levels in Taiwanese Individuals Identifies Functional Haplotypes in CDH13. Genes (Basel). 2021;12(10).
- Gao H, Kim YM, Chen P, et al. Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes. 2013;62(12):4277-83.
- Kitamoto A, Kitamoto T, Nakamura T, et al. CDH13 Polymorphisms are Associated with Adiponectin Levels and Metabolic Syndrome Traits Independently of Visceral Fat Mass. J Atheroscler Thromb. 2016;23(3):309-19.
- Vargas-Alarcon G, Martinez-Rodriguez N, Velazquez-Cruz R, et al. The T>A (rs11646213) gene polymorphism of cadherin-13 (CDH13) gene is associated with decreased risk of developing hypertension in Mexican population. Immunobiology. 2017;222(10):973-8.
- Fava C, Danese E, Montagnana M, et al. A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. Am J Cardiol. 2011;108(10):1432-7.